ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.730,15
0,01%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Idm Pharma (MM) (IDMI)

  7. Idm Pharma (MM) (IDMI) Notícias

IDMI

Idm Pharma (IDMI)

Idm Pharma (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IDMI
DataHoraFonteTítuloCódigoCompanhia
24/06/200917:42Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:IDMIIdm Pharma (MM)
24/06/200917:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDMIIdm Pharma (MM)
24/06/200917:38Edgar (US Regulatory)(25-NSE)NASDAQ:IDMIIdm Pharma (MM)
23/06/200913:42Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:IDMIIdm Pharma (MM)
23/06/200910:40Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:IDMIIdm Pharma (MM)
02/06/200900:14Dow Jones NewsCORRECT: Takeda's Millennium Looking For Deals To Bolster PipelineNASDAQ:IDMIIDM Pharma Inc.
01/06/200916:59Dow Jones NewsTakeda's Millennium Looking For Deals To Bolster PipelineNASDAQ:IDMIIDM Pharma Inc.
28/05/200915:07Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:IDMIIdm Pharma (MM)
26/05/200913:29Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:IDMIIdm Pharma (MM)
26/05/200913:17Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:IDMIIdm Pharma (MM)
19/05/200910:20PR Newswire (US)Stock Alerts on Tuesday's Small and Large-Cap Movers; Issued by Beacon EquityNASDAQ:IDMIIdm Pharma (MM)
18/05/200918:16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:IDMIIdm Pharma (MM)
18/05/200913:28Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:IDMIIdm Pharma (MM)
18/05/200913:05Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:IDMIIdm Pharma (MM)
18/05/200905:00PR Newswire (US)Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 YearNASDAQ:IDMIIdm Pharma (MM)
13/05/200917:42Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:IDMIIdm Pharma (MM)
11/05/200913:18Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IDMIIdm Pharma (MM)
11/05/200908:30PR Newswire (US)IDM Pharma Reports First Quarter Financial ResultsNASDAQ:IDMI
30/04/200914:57Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:IDMIIdm Pharma (MM)
13/04/200908:30PR Newswire (US)IDM Pharma Receives Nasdaq Shareholder Equity NotificationNASDAQ:IDMIIdm Pharma (MM)
03/04/200908:30PR Newswire (US)IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 FiscaNASDAQ:IDMIIdm Pharma (MM)
31/03/200917:30Edgar (US Regulatory)Annual Report (10-K)NASDAQ:IDMIIdm Pharma (MM)
31/03/200908:30PR Newswire (US)IDM Pharma Reports 2008 Financial ResultsNASDAQ:IDMIIdm Pharma (MM)
09/03/200912:26PR Newswire (US)IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, ResectNASDAQ:IDMIIdm Pharma (MM)
26/02/200910:00PR Newswire (US)IDM Pharma Joins NORD to Raise Awareness of Rare DiseasesNASDAQ:IDMIIdm Pharma (MM)
06/02/200917:15Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:IDMIIdm Pharma (MM)
04/02/200915:54Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:IDMIIdm Pharma (MM)
18/12/200816:32PR Newswire (US)IDM Pharma Provides Update on Mifamurtide (MEPACT(R), L-MTP-PE) European Regulatory StatusNASDAQ:IDMIIdm Pharma (MM)
18/11/200810:30PR Newswire (US)IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-MetaNASDAQ:IDMIIdm Pharma (MM)
13/11/200810:30PR Newswire (US)IDM Pharma Reports Third Quarter Financial ResultsNASDAQ:IDMIIdm Pharma (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:IDMI

Seu Histórico Recente

COIN
PTPUST
Platypus
LSE
IDWR
Ishr Msci Wld-i
NYSE
TDW.WS.A
Tidewater
NASDAQ
LDTCW
LeddarTech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados